Wird geladen...
The m(6)A-Related mRNA Signature Predicts the Prognosis of Pancreatic Cancer Patients
N(6)-methyladenosine (m(6)A) has an important epitranscriptomic modification that controls cancer self-renewal and cell fate. The addition of m(6)A to mRNA is a reversible modification. The deposition of m(6)A is encoded by a methyltransferase complex involving three homologous factors, jargonized a...
Gespeichert in:
| Veröffentlicht in: | Mol Ther Oncolytics |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society of Gene & Cell Therapy
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7256444/ https://ncbi.nlm.nih.gov/pubmed/32490170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2020.04.011 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|